Maryland-based life sciences company working to fill the gap and treat NTDs
COLUMBIA, Md., (July 21, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent Venture Funds investment for nearly $350,00 in Zero Point Five Therapeutics. TEDCO’s evergreen Venture Funds are committed to investing in and advancing early-stage technology and life sciences companies across Maryland. These funds provide startups with access to a seasoned team dedicated to supporting their entrepreneurial growth and success.
“Soil-transmitted helminthiases affect around 1.5 billion people each year,” said Joseph Amprey, CEO of Zero Point Five Therapeutics. “However, even with the global burden presented, they remain a low-profile public health priority and disproportionately affect disadvantaged communities. Thanks to TEDCO’s investment, we can continue our research and development efforts to create treatments and help those affected.”
Zero Point Five Therapeutics, located in Baltimore, Md., is committed to developing treatments for neglected tropical diseases (NTDs), a diverse group of communicable diseases that prevail in tropical and subtropical conditions. The first drug candidate from the company, ZP5-9676, aims to be a single-dose, child-friendly therapy to help treat different soil-transmitted parasites like roundworm.
“TEDCO’s Venture Funds are committed to supporting Maryland-based startups in the technology and life sciences sectors,” said Katherine Hill Ritchie, senior director of TEDCO’s Venture Funds. “The work Zero Point Five Therapeutics is doing is one example of the entrepreneurial innovation we are hoping to see grow.”
TEDCO’s evergreen Venture Funds are just one of the many investment opportunities available to qualifying technology-focused startups and small businesses across Maryland. For more information, visit our page at tedcomd.com/funding.
“With the anchors of NIH, FDA and life science giants, Maryland leads as the number one emerging life science hub,” said TEDCO CEO, Troy LeMaile-Stovall. “For researchers and life sciences entrepreneurs looking to start or grow a business, Maryland should not be overlooked.”